ASTROTECH Corp Income (Loss) from Continuing Operations, Per Diluted Share
ASTROTECH Corp (ASTC) reported Income (Loss) from Continuing Operations, Per Diluted Share of -$2713.00 per share for the 12-month period ending 2012-06-30, per its 10-K filed 2012-09-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2012-09-28
- ASTROTECH Corp income (loss) from continuing operations, per diluted share for fiscal 2012 was -$2713.00.
- ASTROTECH Corp income (loss) from continuing operations, per diluted share for fiscal 2011 was -$4983.00.
| Period end | Income (Loss) from Continuing Operations, Per Diluted Share 12 month |
|---|---|
| 2012-06-30 | -$2713.00 10-K · filed 2012-09-28 |
| 2011-06-30 | -$4983.00 10-K · filed 2012-09-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |